Narcolepsy : (Record no. 105238)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 11210nam a22005173i 4500 |
| 001 - CONTROL NUMBER | |
| control field | EBC4386719 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | MiAaPQ |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240729130235.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d | |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cnu|||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 240724s2016 xx o ||||0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9783319237398 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9783319237381 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (MiAaPQ)EBC4386719 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (Au-PeEL)EBL4386719 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (CaPaEBR)ebr11151902 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (CaONFJC)MIL893127 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)936678096 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | MiAaPQ |
| Language of cataloging | eng |
| Description conventions | rda |
| -- | pn |
| Transcribing agency | MiAaPQ |
| Modifying agency | MiAaPQ |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RC1-1245 |
| 082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.8498 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Goswami, Meeta. |
| 245 10 - TITLE STATEMENT | |
| Title | Narcolepsy : |
| Remainder of title | A Clinical Guide. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 2nd ed. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Cham : |
| Name of producer, publisher, distributor, manufacturer | Springer International Publishing AG, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2016. |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | ©2016. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (448 pages) |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Intro -- Dedication -- Preface -- Credits and Acknowledgments -- Contents -- Editors -- Contributors -- Part I: Etiology -- 1: The Genetics of Narcolepsy -- Introduction -- Animal Models of Narcolepsy -- Hypocretin System Genes in Human Narcolepsy -- Narcolepsy and Immune-Related Genes -- Nonimmune System-Related Genes in Narcolepsy -- Conclusion -- References -- 2: Orexin (Hypocretin) and Narcolepsy -- Discovery of Orexin (Hypocretin) -- Disruption of the Orexin System Causes Narcolepsy-Cataplexy -- The Regulation of Sleep and Wakefulness by Orexin Peptides -- Differential Involvement of Deficient OX1R- and OX2R-Mediated Pathways in the Pathophysiology of Narcolepsy -- Effector Neural Circuits That Stabilize Wakefulness Downstream to Orexin Neurons -- Links among Emotion, Narcolepsy, and Orexins -- Conclusions -- References -- 3: Precipitants of Narcolepsy: Vaccines and Infections -- Precipitants of Narcolepsy -- Upper Airway Infections Increase the Risk of Narcolepsy -- Epidemiological Evidence -- Streptococcus pyogenes -- Influenza A Virus -- Infections Precede Narcolepsy Onset -- The 1918 Spanish Flu and Encephalitis Lethargica -- H1N1 Vaccination -- The H1N1 Vaccine Pandemrix Is Associated with Narcolepsy Onset in Children -- The H1N1 Vaccine Pandemrix and Narcolepsy in Adults -- Pandemrix-Associated Narcolepsy Versus Spontaneous Narcolepsy -- Vaccine Composition Matters -- Could an Infection Trigger Narcolepsy with Hypocretin Deficiency? -- References -- Part II: Clinical Considerations -- 4: Epidemiology of Narcolepsy -- Narcolepsy Has a Variable Phenotype -- Difficulties with Diagnosis Complicate Epidemiological Estimates -- Prevalence and Incidence Estimates Vary by Methods and Populations -- Age of Onset Generally Begins in the First Two Decades -- Narcolepsy Without Cataplexy Is More Common Among Men Than Women. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Narcolepsy Has Few Links to Lifestyle Characteristics -- Narcolepsy Has Both a Genetic and Environmental Link -- Seasonality of Birth Gives Clues to Environmental Origins of Narcolepsy -- Looking Ahead: The Future of Epidemiology of Narcolepsy -- References -- 5: Diagnostic Criteria and Delay in Diagnosis of Narcolepsy -- APA DSM-V Narcolepsy Diagnostic Criteria -- ICSD3 Narcolepsy Diagnostic Criteria -- Delay in Diagnosis -- Clinical Features -- Diagnostic Tests -- Conclusion -- References -- 6: Narcolepsy in Childhood -- Historical Notes -- Introduction -- Prevalence -- Clinical Presentation -- Preschool-Age Children -- School-Age Children -- Behavioral, Psychosocial, and School Problems -- Quality of Life -- Metabolic Disturbances -- Twin Studies in Narcolepsy -- Secondary Narcolepsy -- Role of Infections in Triggering Narcolepsy -- Physical Examination -- Diagnosis -- Polysomnography and Multiple Sleep Latency Test -- Sleep Logs -- Histocompatibility Antigen and Other Loci -- CSF Hypocretin Deficiency (Also Known as Orexin Deficiency) -- Computerized Tomography (CT) or Magnetic Resonance Imaging (MRI) -- Questionnaires for Assessing Sleepiness -- Maintenance of Wakefulness Test (MWT) -- Actigraphy -- Differential Diagnoses -- Management -- Temazepam -- Immunotherapy -- Conclusions -- References -- 7: Narcolepsy in the Older Adult -- Introduction -- Narcolepsy Onset After Age 35 -- Case 1 -- Delayed Diagnosis -- Case 2 -- Symptomatic Narcolepsy -- Case 3 -- Implications of Narcolepsy in the Older Adult and Therapeutic Challenges -- Conclusion -- References -- 8: Hypnagogic Hallucinations and Sleep Paralysis -- Introduction -- Hypnagogic Hallucinations -- Clinical Features -- Hypnagogic Hallucinations and Dreams -- Hypnagogic Hallucinations and Schizophrenia -- Hypnagogic Hallucinations and Other Neurological Disorders -- Sleep Paralysis. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Clinical Features -- Isolated Sleep Paralysis and Culturally Determined Interpretations -- Neurobiology of Hypnagogic Hallucinations and Sleep Paralysis -- General View -- Neurobiology of Hallucinations -- Neurobiology of Sleep Paralysis -- Theoretical Conceptualization of Dissociated REM Phenomena -- Treatment of Hypnagogic Hallucinations and Sleep Paralysis -- Sodium Oxybate -- Antidepressant Medications -- Conclusive Remarks -- References -- 9: Symptomatic Narcolepsy or Hypersomnolence with and Without Hypocretin (Orexin) Deficiency -- Introduction -- Definition of Symptomatic Narcolepsy and Its Overview -- Anatomical Substrate for the Symptoms of Narcolepsy -- Hypocretin Status in Various Neurological Conditions -- Hypocretin Status in Symptomatic Narcolepsy-Cataplexy Associated with Distinct CNS Lesions -- Hypocretin Status in Symptomatic Narcolepsy-Cataplexy and/or EDS Associated with Inherited Disorders -- Prader-Willi Syndrome -- Niemann-Pick Type C Disease (NPC) -- Myotonic Dystrophy (MYD) -- Hypocretin Status in Hypersomnia in Various Neurological Conditions -- Focal/Generalized CNS Invasion -- Cerebral Tumors -- Infarctions -- Encephalopathies -- Wernicke's Encephalopathy -- Limbic Encephalopathy -- Rasmussen's Syndrome -- Brain Stem Encephalitis -- Hashimoto's Encephalopathies -- Neurodegenerative Disorders -- Parkinson's Disease (PD) -- Dementia with Lewy Bodies (DLB) -- Progressive Supranuclear Palsy (PSP) -- Alzheimer's Disease (AD) -- Huntington's Disease -- Head Trauma -- CNS Diseases Mediated with Neuroimmune Mechanisms -- Acute Disseminated Encephalomyelitis (ADEM) -- Demyelinating Diseases -- Multiple Sclerosis (MS) and Neuromyelitis Optica (NMO) -- Guillain-Barré Syndrome (GBS) -- Paraneoplastic Syndrome -- Others -- Behçet's Disease -- Conclusion -- Appendix -- References. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 10: Hypersomnias Other Than Narcolepsy: Differential Diagnosis -- Introduction -- Definitions -- Clinical Approach of Excessive Sleepiness -- Laboratory Investigations -- Measures of Sleepiness -- Multiple Sleep Latency test -- Maintenance of Wakefulness Test -- Measures of Total Sleep Time -- Measures of Vigilance -- Psychomotor Vigilance Task (PVT) -- Oxford Sleep Resistance (OSLER) Test -- Sustained Attention to Response Task (SART) -- Brain Imaging -- Psychometric/Psychiatric Evaluation -- Various Causes of Hypersomnia -- Sleep-Related Breathing Disorders -- Obstructive Sleep Apnea Syndrome -- Central Sleep Apnea Syndrome -- Central Disorders of Hypersomnolence -- Idiopathic Hypersomnia -- Kleine-Levin Syndrome -- Hypersomnia Due to Medical Disorders -- Neurologic Disorders -- Infectious and Parasitic Diseases -- Multisystem Diseases -- Endocrine Disorders -- Genetic Disorders -- Hypersomnia Due to a Medication or Substance -- Hypersomnia Associated with a Psychiatric Disorder -- Insufficient Sleep Syndrome -- Conclusion -- References -- 11: Narcolepsy and Other Comorbid Medical Illnesses -- Introduction -- Comorbid Eating Disorders and Obesity -- Diabetes Mellitus -- Psychiatric Disorders -- Fibromyalgia -- Migraines and Other Headaches -- Cognitive Dysfunction -- Psychosocial Comorbidities -- Obstructive Sleep Apnea -- Other: Cardiovascular, Gastrointestinal, and Pulmonary Diseases -- Mortality -- Conclusion -- References -- 12: Sleep Disorder Comorbidities in Narcolepsy -- Introduction -- Sleep Comorbidities in Pediatric Narcolepsy -- Sleep-Related Breathing Disorders -- Circadian Rhythm Disorders and Narcolepsy in Shift Workers -- Parasomnias -- Nightmares -- Sleepwalking -- REM Sleep Behavior Disorder -- Restless Legs Syndrome and Periodic Leg Movements -- Narcolepsy with Cataplexy, Hallucinations, and Psychotic Comorbidity. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Management of Sleep Comorbidities in Narcolepsy -- References -- 13: Neuroimaging of Narcolepsy -- Introduction -- Structural Imaging in Narcolepsy -- Grey Matter Alterations -- White Matter Alterations -- Spectroscopy -- Functional Imaging in Narcolepsy -- Baseline Conditions -- Cataplexy -- Emotional Stimulation -- Neurotransmission -- Summary -- References -- Part III: Psychosocial Considerations -- 14: Quality of Life and Psychosocial Issues in Narcolepsy: Implications for Management -- Introduction -- QOL, Health-Related Quality of Life, and Health Status -- Measuring Health-Related Quality of Life (HRQOL) in Narcolepsy -- The Short Form 36 (SF-36) -- Sickness Impact Profile (SIP) -- Functional Outcomes of Sleep Questionnaire (FOSQ) -- Points to Consider in Critical Appraisal of Research on HRQOL in Narcolepsy -- Quality of Life in Narcolepsy -- Health-Related Quality of Life -- How Do Patients Adjust to a New Way of Life After Successful Treatment of Narcolepsy? -- Can a Disability Have Any Positive Consequences for the Individual and the Family? -- The Value of Social Support -- Support Groups -- Who Can Provide Support? -- Narcolepsy and Support Groups -- Why Do Some Members Not Attend Support Group Meetings? -- What Characteristics Differentiate Those Who Attend Support Groups from Those Who Don't? -- Support Groups/Self-Help Groups and the Internet -- Telephone-Based Peer Support Groups -- Recent Advances in Facilitating Social Well-Being -- Implications for Management of Narcolepsy -- Social Support and Counseling -- Transportation -- Employment -- Research Implications -- References -- 15: Narcolepsy, Intimacy, and Sexuality -- Introduction -- Definitions -- Impact of Symptoms as a Function of Developmental Stage -- Case History: MAG -- Case History: RIL -- Later Adolescence and Early Adulthood. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Adulthood and Nonsexual Aspects of Intimacy. |
| 588 ## - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Description based on publisher supplied metadata and other sources. |
| 590 ## - LOCAL NOTE (RLIN) | |
| Local note | Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neurology. |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Thorpy, Michael J. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pandi-Perumal, S. R. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| Main entry heading | Goswami, Meeta |
| Title | Narcolepsy |
| Place, publisher, and date of publication | Cham : Springer International Publishing AG,c2016 |
| International Standard Book Number | 9783319237381 |
| 797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN) | |
| Corporate name or jurisdiction name as entry element | ProQuest (Firm) |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=4386719">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=4386719</a> |
| Public note | Click to View |
No items available.